Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M1 and M2 muscarinic acetylcholine receptors

被引:47
|
作者
Jakubik, Jan
El-Fakahany, Esam E.
Dolezal, Vladimir
机构
[1] Acad Sci Czech Republ, Dept Neurochem, Inst Physiol, Prague 14220, Czech Republic
[2] Univ Minnesota, Sch Med, Div Neurosci Res Psychiat, Minneapolis, MN 55455 USA
关键词
D O I
10.1124/mol.106.023762
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Xanomeline is a functionally selective M-1/M-4 muscarinic acetylcholine receptor agonist that nevertheless binds with high affinity to all five subtypes of muscarinic receptors. A novel mode of interaction of this ligand with the muscarinic M-1 receptors characterized by persistent binding and receptor activation after extensive washout has been shown previously. In the present study, using human M-1 and M-2 receptors expressed in Chinese hamster ovary cells and [H-3]N-methylscopolamine as a tracer, we show that persistent binding of xanomeline also occurs at the M-2 receptor with similar affinity as at the M-1 receptor (K-I = 294 and 296 nM, respectively). However, kinetics of formation of xanomeline wash-resistant binding to M-2 receptors was markedly slower than to M-1 receptors. Xanomeline was a potent fast-acting full agonist in stimulating guanosine 5'-O-(3-[S-35]thio) triphosphate binding at M-1 receptors, whereas at M-2 receptors it behaved as a potent partial agonist (40% of carbachol maximal response) only upon preincubation for 1 h. Development of xanomeline agonistic effects at the M-2 receptor was slower than its ability to attenuate carbachol responses. We also demonstrate that xanomeline discriminates better between G protein subtypes at M-1 than at M-2 receptors. Our data support the notion that xanomeline interacts with multiple sites on the muscarinic receptor, resulting in divergent conformations that exhibit differential effects on ligand binding and receptor activation. These conformations are both time- and concentration-dependent and vary between the M-1 and the M-2 receptor.
引用
收藏
页码:656 / 666
页数:11
相关论文
共 50 条
  • [1] Activation of multiple G-proteins by muscarinic M1 and M2 receptors.
    Michal, Pavel
    El - Fakahany, Esam
    Dolezal, Vladimir
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 404 - 404
  • [2] Pharmacological determination of the interaction of xanomeline with M1 muscarinic acetylcholine receptors.
    Parsons, AM
    Christopoulos, A
    El-Fakahany, EE
    [J]. LIFE SCIENCES, 1999, 64 (6-7) : 578 - 578
  • [3] Pharmacological analysis of the mode of interaction of xanomeline at M1 muscarinic acetylcholine receptors
    Christopoulos, A
    Parsons, AM
    El-Fakahany, EE
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R85 - R85
  • [4] On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor
    Christopoulos, A
    Pierce, TL
    Sorman, JL
    El-Fakahany, EE
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (06) : 1120 - 1130
  • [5] Transient hypoxia induces sequestration of M1 and M2 muscarinic acetylcholine receptors
    Mou, L
    Gates, A
    Mosser, VA
    Tobin, A
    Jackson, DA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 96 (02) : 510 - 519
  • [6] AGONIST BINDING AND G-PROTEIN ACTIVATION IN CHO CELLS EXPRESSING M1, M2 OR M3-MUSCARINIC-RECEPTORS
    BURFORD, NT
    TOBIN, AB
    NAHORSKI, SR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 : P322 - P322
  • [7] Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes
    Maeda, Shoji
    Qu, Qianhui
    Robertson, Michael J.
    Skiniotis, Georgios
    Kobilka, Brian K.
    [J]. SCIENCE, 2019, 364 (6440) : 552 - +
  • [8] AUTORADIOGRAPHY OF M1 AND M2 MUSCARINIC BINDING IN THE STRIATUM
    NASTUK, MA
    GRAYBIEL, AM
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, : 92 - 93
  • [9] Identification of M1 and M2 muscarinic acetylcholine receptors in the cat carotid body chemosensory system
    Shirahata, M
    Hirasawa, S
    Okumura, M
    Mendoza, JA
    Okumura, A
    Balbira, A
    Fitzgerald, RS
    [J]. NEUROSCIENCE, 2004, 128 (03) : 635 - 644
  • [10] Persistent receptor activation by the M1 muscarinic agonist, xanomeline
    El-Fakahany, EE
    Christopoulos, A
    Pierce, TL
    Sorman, JL
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 32S - 32S